DRKY yields 8.11% · JNJ yields 3.36%● Live data
📍 DRKY pulled ahead of the other in Year 1
Combined, DRKY + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of DRKY + JNJ for your $10,000?
DRKY aims for an annual income target of 15%, distributed monthly, and long-term capital appreciation. The funds strategy involves two components: US equity investing, directly or indirectly through swaps, in a portfolio of the top 20 US-listed equity securities selected by Duquesne Family Office, and income generation through an options portfolio. Option strategies aim for the income target and may be adjusted based on market conditions, risk, and the potential for capital growth. The fund will leverage derivatives such as short-dated, in-the-money call options and swaps for flexibility and tax efficiency. The fund will hold cash or US Treasuries as collateral, carefully balancing income generation with capital appreciation.
Full DRKY Calculator →Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.